OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Cardiology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Racial and ethnic disparities in heart failure: current state and future directions	64
Impact of social determinants of health on cardiovascular disease prevention	50
Hypertension and race/ethnicity	47
Measuring LDL-cholesterol: what is the best way to do it?	36
Hypertension and diabetes mellitus: highlights of a complex relationship	35
Gut microbiome and cardiovascular disease	30
Functional characterization of long noncoding RNAs	29
Recent trends in acute myocardial infarction among the young	26
Hypertension in obesity	25
Genetics of hypertriglyceridemia and atherosclerosis	25
Artificial intelligence and machine learning in aortic disease	24
COVID-19 myocarditis and long-term heart failure sequelae	23
Genetics of dilated cardiomyopathy	22
COVID-19 will forever change the landscape of telemedicine	21
Triglycerides and cardiovascular disease	19
Nutrition and physical activity recommendations from the United States and European cardiovascular guidelines: a comparative review	19
Artificial intelligence in pediatric cardiology: taking baby steps in the big world of data	18
Artificial intelligence in cardiovascular medicine	17
Health anxiety among adults with congenital heart disease	16
Racial disparities in Coronavirus Disease 2019 (COVID-19) outcomes	16
Interactions of hypertension, obesity, left ventricular hypertrophy, and heart failure	16
Risk factors of sudden cardiac death in hypertrophic cardiomyopathy	15
Endocan: a new marker of endothelial function	15
Hypertension in children	15
The aberrant subclavian artery: approach to management	14

The placenta as the window to congenital heart disease	14
Statin intolerance: new data and further options for treatment	13
Pulmonary hypertension associated with left-sided heart failure	13
RNA therapeutics for cardiovascular disease	12
Epidemiology and risk factors for stroke in young individuals: implications for prevention	12
Contemporary perspectives on the genetics and clinical use of lipoprotein(a) in preventive cardiology	12
Management of hypertension in heart failure with preserved ejection fraction: is there a blood pressure goal?	12
Mobile health in preventive cardiology: current status and future perspective	12
Current management of the vascular subtype of Ehlers–Danlos syndrome	12
Racial differences in outcomes after receiving advanced heart failure therapies	12
Emergent expansion of clinical epigenetics in patients with cardiovascular diseases	11
Generalizability of Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial in patients with a history of coronary artery bypass graft surgery	10
The brave new world of genetic testing in the management of the dyslipidaemias	10
Molecular genetics of human hypertension	10
Coronavirus disease 2019: a comprehensive review and meta-analysis on cardiovascular biomarkers	10
RNA-based therapeutics in cardiovascular disease	10
Cybersecurity threats to cardiac implantable devices: room for improvement	10
Mitral valve surgery for rheumatic heart disease: replace, repair, retrain?	10
Genetics of atrial fibrillation	10
Pulsed field ablation: a promise that came true	9
Machine learning: at the heart of failure diagnosis	9
Disparities in acute decompensated heart failure	9
Permission to prescribe: do cardiologists need permission to prescribe diabetes medications that afford cardiovascular benefit?	9
Management of ventricular arrhythmias in patients with LVAD	9
Atrial arrhythmias in patients with left ventricular assist devices	9
Role of epigenetic mechanisms regulated by enhancers and long noncoding RNAs in cardiovascular disease	9
Two-year outcomes from the PARTNER 3 trial: where do we stand?	9
The evolving role of coronary artery calcium in preventive cardiology 30 years after the Agatston score	8
Arrhythmogenic right ventricular cardiomyopathy in the pediatric population	8
Update on pediatric pulmonary arterial hypertension	8
Clinical trials of acute mechanical circulatory support in cardiogenic shock and high-risk percutaneous coronary intervention	8
Pulmonary hypertension in heart failure	8
Challenges in diagnosis and management of coarctation of the aorta	8
The impact of socioeconomic status and race on the outcomes of congenital heart disease	8
Cardiac rehabilitation for coronary artery disease: latest updates	8
Every child with congenital heart disease should be exercising	8
Medical management of resistant hypertension: the role of sodium-glucose cotransporter 2 inhibitors (SGLT2i)	8
Coronary plaque features on CTA can identify patients at increased risk of cardiovascular events	8
Transcatheter mitral valve repair and replacement: the next frontier of transcatheter valve intervention	8
Epigenetic remodeling in heart failure with preserved ejection fraction	7
Genetics of age-related clonal hematopoiesis and atherosclerotic cardiovascular disease	7
Transcatheter mitral valve replacement: an update	7
Opportunities for improved cardiovascular disease prevention in oncology patients	7
A tale of two balloons: technical and procedural difference between cryoballoon systems	7
The landscape of cardiogenic shock: epidemiology and current definitions	7
The emerging role of cardiac contractility modulation in heart failure treatment	7
Reorganizing the treatment of cardiovascular disease in response to coronavirus disease 2019; time for the polypill?	7
Temporary mechanical circulatory support devices: updates from recent studies	7
The cardiac surgeon's guide to artificial intelligence	7
Evaluation of coronary stenosis versus plaque burden for atherosclerotic cardiovascular disease risk assessment and management	7

Multimodality cardiac imaging and new display options to broaden our understanding of the tricuspid valve	7
Cardiovascular implications and complications of the coronavirus disease-2019 pandemic: a world upside down	6
Bicuspid aortic valve associated aortopathy: 2022 guideline update	6
New findings bearing on the prevention, detection and management of high blood pressure	6
Mobile health technologies in the diagnosis and management of atrial fibrillation	6
Pharmacologic therapy for pulmonary artery hypertension	6
Global interventions in hypertension: new and emerging concepts	6
Percutaneous left atrial appendage occlusion	6
Antiplatelet therapy in percutaneous coronary intervention: latest evidence from randomized controlled trials	6
Coronary artery disease in patients with cancer: challenges and opportunities for improvement	6
Long noncoding RNAs in cardiovascular disease	6
Ischaemia without obstructive coronary artery disease: the pathophysiology of microvascular dysfunction	6
The current landscape of lipoprotein(a) in calcific aortic valvular disease	6
Myocardial infarction with nonobstructive coronary artery disease (MINOCA): a review of pathophysiology and management	6
The pleiotropic cardiovascular effects of sodium-glucose cotransporter-2 inhibitors	6
Optimal medical therapy after coronary artery bypass grafting: a primer for surgeons	6
Are the current evaluation tools for advanced therapies biased?	6
Arrhythmias and sudden cardiac death in post-cardiac transplant patients	6
Cardiovascular disease prevention in individuals with underlying chronic inflammatory disease	6
Regionalization of congenital cardiac surgical care: what it will take	6
N-3 polyunsaturated fatty acids for cardiovascular risk	6
Adverse events beyond 1 year after percutaneous coronary intervention	5
A comparison of surgical, total percutaneous, and hybrid approaches to treatment of combined coronary artery and valvular heart disease	5
The shock team: a multidisciplinary approach to early patient phenotyping and appropriate care escalation in cardiogenic shock	5
Cardiovascular effects of preeclampsia	5
Supporting the Ross procedure: preserving root physiology while mitigating autograft dilatation	5
Thin, very thin, or ultrathin-strut biodegradable or durable polymer-coated drug-eluting stents	5
Update on cardiovascular risk in nonalcoholic fatty liver disease	5
Atypical atrial flutter: review of mechanisms, advances in mapping and ablation outcomes	5
Review of transapical off-pump mitral valve intervention with NeoChord implantation	5
Hybrid coronary revascularization: are we there yet?	5
Penetrating atherosclerotic ulcer	5
The role of temporary mechanical circulatory support as a bridge to advanced heart failure therapies or recovery	5
The genetics of left ventricular noncompaction	5
Percutaneous management of coronary bifurcation lesions: current perspective	5
Advances in contemporary medical management to treat patients with heart failure	5
Surgical options for aortic root aneurysm disease: which procedure, which patient	5
Patient-specific preprocedural planning for tricuspid valve repair and replacement procedures	5
Coronary artery bypass grafting in low ejection fraction: state of the art	5
Stress cardiac MRI in stable coronary artery disease	5
Representation of Black patients in heart failure clinical trials	5
Secondary prevention after CABG: do new agents change the paradigm?	5